Restricted use of Leqembi to deal with early Alzheimer’s illness
After re-examining its preliminary opinion, the European Medicines Company’s (EMA) human medicines committee (CHMP) has really ...
Read more
Tag: Leqembi
Biogen’s Leqembi to drive Alzheimer’s market to $14B in 2030
filadendron/E+ by way of Getty Photographs Pushed by novel therapeutics from Biogen (NASDAQ:BIIB)/ Eisai (OTCPK:ESALF) and ...
Read morePremium Content
Copyright © 2022 Real Invest Solutions.